Digital pathology is an image-based information environment for the management and interpretation of pathology information generated from a digitized glass slide. The process involves the conversion of glass slides to digital pathology slides using digital pathology scanning solutions. A digital image is then generated which allows for high-resolution viewing of the slide. "
Visionary leaders are the leading market players in terms of new developments such as product launches, innovative technologies, and the adoption of growth strategies. These players have a broad product offering that caters to most of the regions globally. Visionary leaders primarily focus on acquiring the leading market position through their strong financial capabilities and their well-established brand equity.
Dynamic Differentiators are established players with very strong business strategies. However, they have a weaker product portfolio compared to the visionary leaders. They generally focus only on a specific type of technology related to the product.
Innovators in the competitive leadership mapping are vendors that have demonstrated substantial product innovations as compared to their competitors. The companies have focused on product portfolios. However, they do not have very strong growth strategies for their overall business, when compared with the visionary leaders.
Emerging companies have niche product and service offerings. Their business strategies are not as strong as that of the established vendors. The emerging vendors include the new entrants in the market, emerging in terms of product portfolio and geographic reach, and require time to gain significant traction in the market.
Digital Pathology Products
Buyers Guide
- Enterprise
- SME
- Startups
Digital pathology is an image-based information environment for the management and interpretation of pathology information generated from digitized glass slides. The process involves the conversion of glass slides to digital pathology slides using digital pathology scanning solutions. A digital image is then generated, which allows for high-resolution viewing of the slide.
The global digital pathology market is projected to reach USD 1.1 billion by 2025 at a CAGR of 13%. The growth in the digital pathology market is mainly driven by factors, such as the increasing adoption of digital pathology to enhance lab efficiency, rising prevalence of cancer, growing application of digital pathology in drug development and companion diagnostics, and increasing initiatives by industry players. On the other hand, the high cost of digital pathology systems is projected to restrict the market growth to a certain extent.
Increased demand for personalized medicines to boost Digital Pathology market
This report identifies and benchmarks the best Digital Pathology vendors globally such as Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), Hamamatsu Photonics (Japan), Roche (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), and evaluates them on the basis of business strategy excellence and strength of product portfolio within the Digital Pathology ecosystem, combining inputs from various industry experts, buyers, and vendors, and extensive secondary research including annual reports, company press releases, investor presentations, free and paid company databases. They are rated and positioned on a 2x2 matrix, called as ‘Company Evaluation Quadrant’, and identified as Visionary Leaders (top companies), Dynamic Differentiators, Innovators, or Emerging companies.
The report includes market-specific company profiles of 20 top Digital Pathology vendors and assesses the recent developments that shape the competitive landscape of this highly fragmented market. An in-depth analysis of the best Digital Pathology vendors is done at a granular level to create this report.
This report identifies and benchmarks the best Digital Pathology vendors globally such as Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), Hamamatsu Photonics (Japan), Roche (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), and evaluates them on the basis of business strategy excellence and strength of product portfolio within the Digital Pathology ecosystem, combining inputs from various industry experts, buyers, and vendors, and extensive secondary research including annual reports, company press releases, investor presentations, free and paid company databases. They are rated and positioned on a 2x2 matrix, called as ‘Company Evaluation Quadrant’, and identified as Visionary Leaders (top companies), Dynamic Differentiators, Innovators, or Emerging companies.
SAMPLES:
- Updated version of this Quadrant
- Different Company Evaluation Quadrant
- 'Startup Only' Company Evaluation Quadrant
- Region or Country specific evaluation
- Application or Industry specific evaluation ..Read More
- Submit a Briefing Request
- Question about our published research
- Request for evaluation of your organization for specific market
- Request for re-evaluation of Company Evaluation Quadrant ..Read More
